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Abstract
The aim of the study is to review the historical stages of development of the requirements of good pharmaceutical 
practice (GPP), generalization of the normative documents recommended by the International pharmaceutical 
company (MFP) for use in the world of pharmaceutical practice. Methods of generalization of the information 
material and system analysis were used in the study. Historical stages of the development of the concept of 
the GPP in the world and the role of the World Health Organization and the FIP in the process were analyzed. 
Researches of professional standards of pharmacy practice in developed countries reveal different approaches 
to the regulation of such activities, however, despite the applicable model standards are developed by the 
pharmaceutical associations and are used by regulatory bodies, business owners, and professionals to control 
the quality of pharmacy services that are provided to the population. The study indicates that the development of 
the GPP standards should be resolved at the level of public professional organizations as the national regulation 
of pharmacy practice in different countries varies significantly. Prospects of further scientific researches are 
aimed on using the results of the study while developing and implementing national standards of the GPP in 
the world.
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INTRODUCTION
The pharmaceutical practice varies in different countries and continents, including developing countries, 
transitional and developed countries. The standard 
of quality of pharmacy services, that is the joint 
guideline of the World Health Organization 
(WHO)/International Pharmaceutical Federation 
(FIP) of the Good pharmacy practice (GPP) 
updated in 2011, is intended to take into account 
these changes in practice.
The profession of pharmacist is currently 
growing fast, and new roles are being offered 
and proclaimed not only by the profession but 
also by other medical professionals and national 
and organizations and institutions. The guideline 
of the GPP is visionary and flexible, and it has to 
retain its relevance with the emergence of new 
roles. One of the main methods of quality control 
of medicines and pharmaceutical services for the 
population is to standardize various aspects of 
pharmacies. Guide of the GPP is an important step toward the 
improvement of pharmacy services.[1]
The WHO and FIP emphasize that the guideline of the GPP 
is intended for use by national professional pharmaceutical 
associations as well as by national authorities and other 
relevant bodies responsible for drawing up the relevant 
documents and related laws and regulations in their countries. 
It is not a set national standard, but it provides guidance on 
specific achievable roles, functions, and activities, which 
execute the mission of pharmacy practice in the new 
millennium.
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Considering the text of the entire guideline, a special 
importance is given to professional issues and attitudes, and 
welfare of the patient has a paramount importance. However, 
it should be noted that it is the first time when legal, economic, 
and labor framework in the context of the structure of the GPP 
is introduced, and it is quite in time considering worldwide 
debates on the economic aspects of medicines, access to 
quality medicines, access to skilled medical workers, the 
global failure of the workforce, the increased cost of medical 
care, and new models of pharmacy practice.[2]
The WHO and FIP define the GPP as a pharmacy practice that 
meets the needs of people who use services of pharmacists to 
provide optimal medical care on the principles of evidence-
based medicine. To support this practice, it is necessary to 
create a national system of quality standards and guidelines.
The work purpose is the research of historical stages of 
development of the GPP requirements and examination of 
modern normative documents, recommended by FIP to use in 
the global pharmaceutical practice, and study of the current 
status of this issue in the world.
Methods of generalization of the information material and 
system analysis were used in the study.
Since the late 80s, the WHO and the FIP have been working 
toward defining the roles and functions of pharmacists, as 
well as developing guidelines for the GPP as the framework 
of pharmaceutical care.
The Medicines Strategy, adopted by the World Health Assembly 
in 1986, was revised by the WHO, and according to it, there 
were two meetings regarding the role of pharmacist organized. 
The first meeting took place in 1988 in Delhi, India.[3]
In 1992, the FIP developed standards for pharmaceutical 
services - the methodology of good pharmaceutical practice, 
spread by the WHO Information Centers in March 1993. 
During the congress in Tokyo, Japan, the standards of 
pharmacy services entitled “GPP in Public and Hospital 
Pharmacies” were officially published.[4]
The FIP congress adopted the FIP/GPP text under the auspices 
of the Tokyo declaration on quality standards of pharmacy 
services. According to this document, the FIP has urged 
pharmaceutical companies and governments to cooperate 
to implement standards for the GPPs or to revise existing 
national standards in countries where they already exist.
Then, in May 1994, a resolution of the World Health Assembly 
WHA47.12 on the role of the pharmacist in support of the 
revised strategy of the WHO for medicines was adopted.
A text of the GPP was also submitted to the Expert Committee 
of the WHO on specifications of pharmaceutical medicines in 
1994 in Geneva.
According to recommendations of the WHO Expert 
Committee and the approval of the Board of the FIP in 
1997, a joint document of the WHO/FIP of the GPP was 
published in 1999 in a series of technical reports of the 
WHO Expert Committee on questions of the specification of 
pharmaceutical medicines. This provided recommendations 
of the GPP, a more formal status, and ensured its wide 
distribution in the world.[5]
Soon the WHO organized two more meetings on the role of 
the pharmacist in 1997 in Vancouver, Canada, and in 1998 in 
Hague, the Netherlands. These meetings confirmed the need 
to reform the pharmaceutical education programs and noted 
the role of the pharmacist in self-help and self-healing.
Pharmaceutical group of the European Union (the EU) in 
1998 developed a document with the GPP for Europe in 
which particular attention was paid to the EU countries - “the 
GPP in Europe.”[6]
In 2001, the “GPP in the New Independent States. Guidelines 
for the development and implementation of standards” was 
developed in Denmark by the Copenhagen center of drug 
policy and development of pharmaceutical practice. The 
document analyzed the state of practice of pharmacies and 
focused attention on issues of education of responsibility 
for own health and prevention of morbidity, the provision 
of prescription drugs and their use, self-treatment, the effect 
from prescription and use of drugs, as well as the method 
of step-by-step implementation of proper pharmacy practices 
in developing countries and countries in transition. The 
WHO experts suggested to implement European standards 
for pharmacies on the level of existing national standards 
to regulate various aspects of pharmaceutical activity, in 
particular the quality of the prescription data received by the 
pharmacist; development of medical forms; building contacts 
with doctors according to individual recipes; evaluation 
of data on the use of medical products in medical and 
pharmaceutical practice; construction and implementation 
of educational programs for health-care workers; conducting 
of advertising campaigns and spreading of information; and 
the question of a building of a privacy policy for information 
about individual patients.[7]
According to FIP recommendations, there is a strategy for 
implementing of national standards of GPP. First of all, basic 
pharmaceutical services are set up, for which the regulatory 
framework and relevant standards should be developed. 
After that, the system of secondary and higher education in 
pharmacy should be changed, since pharmacists will need 
more in-depth knowledge of pharmacotherapy, pharmacopeia, 
and communicative skills. The final stage is the provision of 
more complex professional pharmaceutical services.
The FIP highlights such GPP elements that demonstrate 
that the pharmacy provides qualitative assistance and works 
according to high standards: Availability of pharmacist on 
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change; availability of a pharmacy for people with disabilities 
and elderly patients; availability of a comfortable waiting 
area; the possibility of a private conversation between a 
pharmacist and a patient, including those with disabilities; 
and presence in the pharmacy of a zone with information 
about healthy lifestyle.
According to FIP’s recommendations, the role of the 
pharmacist in providing effective drug therapy is as follows: 
Management of therapy, monitoring the effectiveness of 
treatment, and providing information on the rational use of 
medicines. The pharmacist should assess the health and needs 
of the client, taking into account his individual characteristics.
An important aspect of GPP is the professional collaboration 
between the pharmacist and the doctor. The first one should 
have the necessary medical and pharmaceutical information 
(diagnosis and laboratory data) for each patient.
It is also important to monitor the compliance with GPP 
standards. It can be internal and/or external; it also may 
be mandatory or only for the purpose of accreditation/
certification. This will reveal the disadvantages of fulfilling 
GPP requirements, as well as provide recommendations for 
their elimination. One of the simplest methods of controlling 
the quality of a pharmacy’s work is to evaluate customer’s 
satisfaction with the service.
In cooperation, FIP and WHO published the handbook 
“developing of the pharmacy practice - a focus on the 
patient” in 2006. This handbook describes the new paradigm 
of the pharmacy practice, and the approach to pharmaceutical 
help is introduced.
To improve standards and practice of distribution and use of 
medicines with the help of the setting of the WHO/FIP with 
the GPP as the framework, the FIP has taken the initiative to 
explore the possibilities of providing technical assistance to 
its member organizations in Cambodia, Moldova, Mongolia, 
Paraguay, Thailand, Uruguay, and Vietnam in developing of 
national standards of the GPP in a pilot study from 2005 to 
2007.
In 2007, in Southeast Asia, the “Bangkok declaration of the 
GPP in public pharmacies” was adopted, and commitments of 
member associations for improving the quality of pharmacy 
services and professional practice were introduced.[8]
After accepting the guideline of the GPP in community and 
hospital settings, significant changes have occurred in the 
practice, applied science and technology, and pharmaceutical 
policy. Despite changes that have occurred since the adoption 
of the previous guidance of the GPP in the pharmaceutical 
policy, practice, and applied science in 2007, FIP was initiated 
to investigate the problem of updating the guiding principles 
of the GPP taking into account the modern standards of the 
present time and peculiarities of professional thinking.[9]
For this purpose in 2008, the FIP organized expert consultations 
in Basel, Switzerland, during the 68th World Congress. The 
meeting was attended by 50 participants, including the working 
group (WG), FIP of the GPP, the WHO staff from headquarters, 
representatives of the WHO regional office for the Eastern 
Mediterranean countries, the medicines advisers from Ghana, 
Nigeria, and the United Republic of Tanzania, presidents and 
secretaries of six Regional Pharmaceutical Forums, member 
organizations of FIP, and several invited international experts.[10]
After these consultations, the WG of FIP of the GPP has 
conducted an extensive investigation of the existing national 
standards for GPP in at least 37 countries and established a 
time frame that may allow carrying out adequate consultations 
with all 120 National Associations - members of FIP, relevant 
experts, and the WHO. The proposal concerning this initiative 
was presented at the 43rd meeting of the WHO expert Committee 
on questions of the specification of pharmaceutical medicines 
in October 2008 and an updated report was presented to the 
Committee of Experts at its 44th meeting in October 2009.
At the same time, in the end of 2008, the Pan-American 
health organization with the support of a group of experts 
from different pharmaceutical organizations was prepared 
“the guide for pharmaceutical services in primary health 
care” with the aim of underlining the role of pharmaceutical 
experts in the health system of Latin America.
Taking into consideration the consultations with 120 national 
members of the FIP in 2011 and changes in the pharmaceutical 
market, guidelines of the GPP through the adoption of a joint 
guideline FIP/WHO “the GPP: Standards of the quality of 
pharmacy services” were adopted and updated. This general 
guideline was published in the 45th report of the WHO Expert 
Committee as new standards of the quality of pharmacy 
services. Furthermore, this document calls national pharmacy 
professional organizations to adopt these guidelines and 
develop some special rules for the GPP.[11]
The GPP sets the standards that are usually higher than the 
requirements of the pharmaceutical legislation of the given 
country. There are several roles of pharmacists in the updated 
version of the GPP:
1. Manufacture, receipt, storage, security, distribution, use, 
release, and disposal of medical products.
2. Ensuring the effective management of the drug therapy.
3. Maintaining and improving of professional activity.
4. Promoting the increasing of the effectiveness of the 
system of medical care and health.[9]
These roles may vary for each pharmacist depending on duties 
they perform. Specific standards of the GPP can be developed 
only within national pharmacy professional organizations.
This guideline is recommended in the form of a set of 
professional goals that must meet the interests of patients and 
other stakeholders in the pharmaceutical sector.
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Thus, in comparison with the previously approved concept 
of the GPP, the current updated version strengthens the 
requirements for the already known main elements of the 
GPP and highlights certain functions in each pharmacist’s 
role for which minimum national standards should be set.
In different countries, the rules of the GPP exist in different 
forms. In some countries, there are holistic documents, where 
both requirements of material-technical base, facilities, 
personnel, and standards for the provision of pharmaceutical 
care are included. In other countries, these standards and 
requirements are set out in various documents. For example, 
in France, the standards for pharmacists are outlined in 
numerous guidelines. In Austria, on the contrary, almost all 
the requirements for pharmacists are joined in one law. There 
is also a guideline about the work of pharmacies, in which 
despite usual requirements for premises, equipment and staff 
there are also requirements for quality management system. In 
developed countries, the GPP standards have a recommended 
character. Hence, standards of pharmacy practice of Norway 
developed by the Norwegian pharmaceutical association 
in collaboration with other professional bodies contain 
requirements for activities of pharmacies that are used 
by the owners of the pharmacy business to conduct the 
internal quality control of pharmacy services. The minimum 
requirements for the operation of pharmacies are approved in 
legal acts that are adopted by the government.[12]
Pharmaceutical Society of Ireland issued Guideline on 
pharmacy practice to assist pharmacists in fulfilling 
legislative and regulatory requirements in providing 
pharmacy services.[13]
Furthermore, the GPP is implemented in countries of the CIS. 
Thus, in particular, Belarus has introduced a categorization 
of pharmacies. In Kazakhstan, the GPP was adopted in 2006, 
and in the Russian federation, rules of the GPP of the customs 
union were currently accepted.
It should be noted that the GPP standard and guidance on 
the implementation of proper pharmacy practices are the 
basis for implementing the concept of the total quality 
management (TQM), which has been operating in the world 
for more than 30 years, and the international standard of 
ISO quality management at pharmaceutical companies. The 
basis of the TQM is the understanding of the existence of 
an inextricable link between the quality management system 
and the management system of the organization, as well as 
the understanding that this is an essential tool for continuous 
improvement and increasing the competitiveness of the 
pharmacy organization in any market.[14]
CONCLUSION
Hence, the GPP standards are an important step toward the 
expansion and improvement of activities of pharmacies 
by raising the requirements to ensure the quality of public 
services.
Development and implementation of the GPP requirements 
into the practical activity of pharmacies are a long-term 
and continuous process, despite changes in pharmaceutical 
science and practice.
In guides of the GPP of editions of all years, the big attention 
is paid on standardization of work of pharmacists of the 
provision of the population with medicines and medical 
products. The development of the GPP standards should be 
resolved at the level of public professional organizations 
as the national regulation of pharmacy practice in different 
countries varies significantly.
The prospects of further scientific researches are aimed 
on using the results of the study while developing and 
implementing national standards of the GPP in the world.
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